Taking ivermectin reduces the risk of COVID-19 infection by 83 percent
the verdict
REFUTED
the evidence says no
confidence 2/100
Clinical trials and scientific evaluations have found no credible evidence that ivermectin significantly reduces the risk or severity of COVID-19 infection.
Evidence against · 3
Efficacy and safety of ivermectin in the treatment of mild-to-moderate COVID-19 infection: A randomized, double blind, placebo, controlled trial
2022 · cited by 1
Randomized controlled trial found no significant difference in virologic clearance or major clinical outcomes between ivermectin and placebo groups.
See more details
More against · 2
Efficacy of Single-Dose Ivermectin on Virologic and Clinical Recovery in COVID-19
2021 · cited by 1
Prospective randomized controlled trial concluded that approved doses of ivermectin do not produce significant virologic or clinical recovery in COVID-19.
HIV-1 versus SARS-CoV-2 infection: understanding the population genetic aspects of drug inefficacy (especially ivermectin) in the integrase-importin complex
2020 · cited by 0
Genetic and molecular analysis explains the lack of efficacy of ivermectin against SARS-CoV-2 at population levels.